Clinical TrialsSearch results
Number of results: 550
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Multicenter Phase II Randomized Controlled Trial of S-1 and Interferon-alpha Combined Chemotherapy or S-1 Alone in Advanced Hepatocellular Carcinoma with Extrahepatic Metastasis
- Advanced hepatocellular carcinoma with extrahepatic metastasis
- Graduate School of Medicine, Osaka University Department of Surgery
- 2007-07-26
Completed
- VAC-XAGE Clinical Trial
- Advanced lung adenocarcinoma
- Oka Mikio
- 2018-12-11
Other
- Randomized phase III trial of Docetaxel versus docetaxel plus S-1 for second-line treatment of non-small cell lung cancer (NSCLC)
- Advanced non-small cell lung cancer
- The Japan-multinational Trial Organization
- 2009-03-31
Other
- A randomized phase II study designed to compare toxicity and dose intensity between four-week versus three-week schedule of gemcitabine for advanced pancreatic cancer
- Advanced nonresectable pancreatic cancer
- Okayama University Hospital
- 2008-01-08
Other
- Randomized phase III study of TS-1 alone versus TS-1 plus Lentinan(LNT) in advanced or recurrent gastric cancer (AGC)
- Advanced or recurrent gastric cancer (AGC)
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- 2007-01-20
Completed
- BNCT for head and neck malignancies
- Advanced or recurrent head and neck malignancies
- Kamitani Nobuhiko
- 2019-03-19
Completed
- BNCT for skin malignancies
- Advanced or recurrent skin malignancies
- Kamitani Nobuhiko
- 2019-03-19
Recruiting
- A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation
- Advanced/metastatic NSCLC with Exon 20 insertions and Uncommon/Single or Compound EGFR Mutations
- Dempke Wolfram
- 2023-09-12
Completed
- Therapeutic apps for control drinking or abstinence: A feasibility randomized controlled study
- alcohol dependence
- NOUSO Kazuhiro
- 2021-05-25
Other
- Phase II Study of Amrubicin in Patients with Non-Small Cell Lung Cancer Previously Treated with Platinum-Based Chemotherapy
- All patients had histologocally or cytologically confirmed locally advanced (non-irradiated) or metastatic NSCLC, with failure of platinum-based chemotherapy (exception for UFT and gefitinib).
- West Japan Oncology Group
- 2005-08-22